Paper Details

  1. Home
  2. Paper Details

Efficacy and tolerability of alendronate once weekly in Asian postmenopausal osteoporotic women.

Author: HoAndrew Y Y, KungAnnie W C

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Osteoporosis is a growing problem worldwide, including in Asia. Bisphosphonates, a type of medication, are commonly used to treat osteoporosis after menopause. How often these medications are taken may affect how well they are tolerated and how likely people are to continue taking them.
Paper Details　
Original Abstract of the Article :
Osteoporosis has become a major health problem worldwide, and the incidence is rising in Asian countries. The aminobisphosphonates are potent inhibitors of bone resorption and are currently the mainstay of treatment for postmenopausal osteoporosis. Dosing frequency will likely affect tolerability an...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1345/aph.1E580

データ提供：米国国立医学図書館（NLM）

Alendronate Once Weekly: A Convenient Approach to Osteoporosis Treatment

This study explores the efficacy and tolerability of alendronate, a potent bone resorption inhibitor, administered once weekly in Asian postmenopausal women with osteoporosis. The researchers investigated the impact of dosing frequency on treatment adherence and tolerability, a crucial aspect of long-term osteoporosis management.

Weekly Dosing: A Comfortable Option for Osteoporosis Management

The study suggests that once-weekly dosing of alendronate is well-tolerated and may improve adherence to treatment. This could be a significant advantage for patients, enhancing their ability to manage their osteoporosis effectively and prevent bone loss over the long term.

Managing Osteoporosis: A Balancing Act

Osteoporosis is a silent thief, gradually weakening bones and increasing the risk of fractures. Finding effective and convenient treatment options is crucial for managing this condition and improving quality of life. This research highlights the potential of once-weekly alendronate as a viable option for managing osteoporosis in postmenopausal women, offering a more manageable approach to maintaining bone health.

Dr.Camel's Conclusion

This study explores the potential of a weekly alendronate dose for osteoporosis management, offering a more convenient approach to this debilitating condition. Just like a desert traveler relies on a reliable supply of water, individuals with osteoporosis need a consistent and manageable treatment regimen. This research suggests that weekly alendronate dosing may provide a comfortable and effective solution for maintaining bone health.

Date :
  1. Date Completed 2005-10-26
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

16076919

DOI: Digital Object Identifier

10.1345/aph.1E580

Related Literature

Article Analysis
・Effective treatment of osteoporosis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.